Travel in the Time of COVID: A Review of International Travel Health in a Global Pandemic.

Health passport Quarantine SARS-CoV-2 Sustainable travel Testing Transmission Transport Travel medicine Vaccine

Journal

Current infectious disease reports
ISSN: 1523-3847
Titre abrégé: Curr Infect Dis Rep
Pays: United States
ID NLM: 100888983

Informations de publication

Date de publication:
2022
Historique:
accepted: 25 07 2022
pubmed: 16 8 2022
medline: 16 8 2022
entrez: 15 8 2022
Statut: ppublish

Résumé

This review critically considers the impact of the COVID-19 pandemic on global travel and the practice of travel medicine, highlights key innovations that have facilitated the resumption of travel, and anticipates how travel medicine providers should prepare for the future of international travel. Since asymptomatic transmission of the virus was first recognized in March 2020, extensive efforts have been made to characterize the pattern and dynamics of SARS-CoV-2 transmission aboard commercial aircraft, cruise ships, rail and bus transport, and in mass gatherings and quarantine facilities. Despite the negative impact of further waves of COVID-19 driven by the more transmissible Omicron variant, rapid increases of international tourist arrivals are occurring and modeling anticipates further growth. Mitigation of spread requires an integrated approach that combines masking, physical distancing, improving ventilation, testing, and quarantine. Vaccines and therapeutics have played a significant role in reopening society and accelerating the resumption of travel and further therapeutic innovation is likely. COVID-19 is likely to persist as an endemic infection, and surveillance will assume an even more important role. The pandemic has provided an impetus to advance technology for telemedicine, to adopt mobile devices and GPS in contact tracing, and to apply digital applications in research. The future of travel medicine should continue to harness these novel platforms in the clinical, research, and educational arenas.

Identifiants

pubmed: 35965881
doi: 10.1007/s11908-022-00784-3
pii: 784
pmc: PMC9361911
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

129-145

Informations de copyright

© The Author(s) 2022.

Déclaration de conflit d'intérêts

Conflict of InterestDr. Flaherty has received conference registration support as an Executive Board member of the Travel Medicine Society of Ireland (former) and International Society of Travel Medicine (current). Dr. Chen reports honoraria from Shoreland Inc, Valneva, Takeda, Sanofi-Pasteur, Emergent BioSolutions, and Merck. Dr. Hamer reports consulting fees and honoraria from Xenophon Strategies, Inc., Trinity Biotech, LLC, Equinox, Major League Soccer, PGA of America, Valneva, and Takeda.

Références

Emerg Infect Dis. 2020 Aug;26(8):1933-1935
pubmed: 32339092
Eur J Clin Invest. 2022 Apr;52(4):e13743
pubmed: 35000189
J Travel Med. 2020 Dec 23;27(8):
pubmed: 32975554
Emerg Infect Dis. 2021 May;27(5):1274-1278
pubmed: 33734063
Nat Med. 2022 Mar;28(3):456-459
pubmed: 35273403
PLoS Pathog. 2021 Mar 19;17(3):e1009374
pubmed: 33740028
N Engl J Med. 2021 Jul 8;385(2):179-186
pubmed: 34161052
Clin Infect Dis. 2022 Feb 11;74(3):490-497
pubmed: 33978720
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Emerg Infect Dis. 2020 Dec;26(12):2872-2880
pubmed: 32990563
MMWR Morb Mortal Wkly Rep. 2020 Jul 17;69(28):904-908
pubmed: 32673296
Public Health. 2022 Mar;204:49-53
pubmed: 35172222
Lancet Infect Dis. 2022 Sep;22(9):e254-e266
pubmed: 35429463
J Travel Med. 2021 Oct 11;28(7):
pubmed: 34343308
Int J Infect Dis. 2021 Mar;104:175-177
pubmed: 33482380
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
J Migr Health. 2021;3:100041
pubmed: 33903857
J Travel Med. 2022 Sep 17;29(6):
pubmed: 35532195
Emerg Infect Dis. 2020 Nov;26(11):2617-2624
pubmed: 32946369
Euro Surveill. 2022 Jan;27(1):
pubmed: 34991781
J Travel Med. 2020 Dec 23;27(8):
pubmed: 33152761
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):347-352
pubmed: 32214086
J Travel Med. 2021 Dec 29;28(8):
pubmed: 34609486
J Travel Med. 2021 Oct 11;28(7):
pubmed: 34323275
J Travel Med. 2020 Dec 23;27(8):
pubmed: 32841356
N Engl J Med. 2022 Feb 10;386(6):509-520
pubmed: 34914868
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32010938
J Travel Med. 2021 Jun 1;28(4):
pubmed: 33550418
J Travel Med. 2021 Dec 29;28(8):
pubmed: 34494115
J Travel Med. 2020 Dec 23;27(8):
pubmed: 33184655
J Travel Med. 2020 Aug 20;27(5):
pubmed: 32662867
Viruses. 2022 May 17;14(5):
pubmed: 35632810
J Travel Med. 2020 Nov 9;27(7):
pubmed: 32869843
Ann Intern Med. 2021 Apr;174(4):511-520
pubmed: 33370173
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32433907
J Travel Med. 2020 May 18;27(3):
pubmed: 32109273
J Travel Med. 2021 Oct 11;28(7):
pubmed: 34230969
BMJ Glob Health. 2022 May;7(5):
pubmed: 35577391
MMWR Morb Mortal Wkly Rep. 2021 Feb 19;70(7):254-257
pubmed: 33600386
Int J Infect Dis. 2021 Apr;105:243-244
pubmed: 33640569
Travel Med Infect Dis. 2022 May-Jun;47:102313
pubmed: 35306163
J Travel Med. 2022 May 31;29(3):
pubmed: 35325195
J Travel Med. 2021 Dec 29;28(8):
pubmed: 34542623
JAMA. 2022 Jan 18;327(3):217-218
pubmed: 34989763
J Travel Med. 2020 Aug 20;27(5):
pubmed: 32463446
J Travel Med. 2020 Dec 23;27(8):
pubmed: 33247588
Travel Med Infect Dis. 2022 May-Jun;47:102285
pubmed: 35314345
J Travel Med. 2021 Dec 29;28(8):
pubmed: 34609481
J Travel Med. 2022 May 31;29(3):
pubmed: 34791355
Can J Public Health. 2022 Feb;113(1):126-134
pubmed: 35060107
Sci Total Environ. 2021 Mar 20;761:144148
pubmed: 33360135
J Travel Med. 2020 Dec 23;27(8):
pubmed: 33043363
Trop Dis Travel Med Vaccines. 2020 Aug 28;6:16
pubmed: 32868984
Emerg Infect Dis. 2022 Mar;28(3):501-509
pubmed: 34965365
J Travel Med. 2020 Aug 20;27(5):
pubmed: 32463093
J Travel Med. 2021 Feb 23;28(2):
pubmed: 33410482
Int J Infect Dis. 2022 May;118:10-20
pubmed: 35189341
Clin Infect Dis. 2021 May 18;72(10):e448-e457
pubmed: 32785683
J Travel Med. 2021 Feb 23;28(2):
pubmed: 32856040
J Travel Med. 2021 Oct 11;28(7):
pubmed: 34369562
Emerg Infect Dis. 2020 Nov;26(11):2713-2716
pubmed: 32946370
J Travel Med. 2021 Jun 1;28(4):
pubmed: 33772312
J Travel Med. 2022 Sep 17;29(6):
pubmed: 35238928
J Travel Med. 2020 Dec 23;27(8):
pubmed: 32870275
Emerg Infect Dis. 2022 Jul;28(7):1527-1530
pubmed: 35483111
Vet World. 2022 May;15(5):1237-1245
pubmed: 35765482
J Travel Med. 2021 Oct 11;28(7):
pubmed: 34480171
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
J Travel Med. 2020 Dec 23;27(8):
pubmed: 33247586
Int J Environ Res Public Health. 2020 Sep 16;17(18):
pubmed: 32947859
J Travel Med. 2021 Dec 29;28(8):
pubmed: 34654928
Lancet Infect Dis. 2022 May;22(5):657-667
pubmed: 35247320
Curr Opin Infect Dis. 2021 Oct 1;34(5):415-422
pubmed: 34524196
MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):238-242
pubmed: 35176004
N Engl J Med. 2022 Apr 14;386(15):1397-1408
pubmed: 35172054
J Travel Med. 2020 Mar 13;27(2):
pubmed: 31776567
J Travel Med. 2021 Dec 29;28(8):
pubmed: 34581403
MMWR Morb Mortal Wkly Rep. 2021 Apr 23;70(16):595-599
pubmed: 33886531
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
J Travel Med. 2020 Dec 23;27(8):
pubmed: 32877520
Emerg Infect Dis. 2021 Mar;27(3):687-693
pubmed: 33400642
J Travel Med. 2020 Aug 20;27(5):
pubmed: 32597473
J Travel Med. 2020 Dec 23;27(8):
pubmed: 32841354
Lancet. 2021 Dec 18;398(10318):2211-2213
pubmed: 34871546
Ann Intern Med. 2022 Jun;175(6):892-894
pubmed: 35404669
J Travel Med. 2020 Dec 23;27(8):
pubmed: 33009813
Int J Infect Dis. 2022 May;118:126-131
pubmed: 35247549
N Engl J Med. 2022 Jun 9;386(23):2188-2200
pubmed: 35443106
Science. 2021 Feb 5;371(6529):
pubmed: 33303686
Public Health Pract (Oxf). 2022 Jun;3:100255
pubmed: 35403074
BMC Public Health. 2021 Jan 9;21(1):110
pubmed: 33422034
J Travel Med. 2021 Dec 29;28(8):
pubmed: 34345917
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):243-248
pubmed: 35176005
JAMA. 2022 Apr 5;327(13):1229-1230
pubmed: 35244685
J Travel Med. 2022 May 31;29(3):
pubmed: 35134222
J Travel Med. 2021 Oct 11;28(7):
pubmed: 34046663
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246

Auteurs

Gerard T Flaherty (GT)

School of Medicine, University of Galway, Galway, Ireland.
School of Medicine, International Medical University, Kuala Lumpur, Malaysia.

Davidson H Hamer (DH)

Department of Global Health, Boston University School of Public Health, Boston, MA USA.
Section of Infectious Diseases, Boston University School of Medicine, Boston, MA USA.
Center for Emerging Infectious Disease Research and Policy, Boston University, Boston, MA USA.
National Emerging Infectious Disease Laboratory, Boston University, Boston, MA USA.

Lin H Chen (LH)

Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, Cambridge, MA USA.
Harvard Medical School, Boston, MA USA.

Classifications MeSH